Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.

Neurogastroenterology and motility - 1 Dec 2015

Dlugosz A, Nowak P, D'Amato M, Mohammadian Kermani G, Nyström J, Abdurahman S, Lindberg G

Abstract excerpt

BACKGROUND: Innate immune responses to conserved microbial products such as lipopolysaccharide (LPS) and flagellin are likely important in microbial-host interactions and intestinal homeostasis. We hypothesized that bacterial translocation and activation of mucosal immunity against common microbial antigens might be involved in the development of irritable bowel syndrome (IBS). We therefore compared serum levels...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Antigens, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diarrhea

Share to Flagellin

Share to Irritable Bowel Syndrome

Share to Lipopolysaccharide Receptors

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Toll-Like Receptors

Source

Identifiers

PMID: 26387872
DOI: 10.1111/nmo.12670

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.PMID 26387872Read ↗

Irritable bowel syndrome: emerging paradigm in pathophysiology.Semantic proximity Read ↗

Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseasesSemantic proximity Read ↗

Global burden of irritable bowel syndrome: trends, predictions and risk factors.Semantic proximity Read ↗

Role of Small Intestinal Bacteria Overgrowth in Irritable Bowel Syndrome and Anxiety: A Retrospective Electronic Health Record (EHR)- Based Cohort Study Using TriNetXSemantic proximity Read ↗

Irritable bowel syndrome - from etiopathogenesis to therapy.Semantic proximity Read ↗

Recent developments in the pathophysiology of irritable bowel syndrome.Semantic proximity Read ↗

Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn’s disease and chronic fatigue syndromeSemantic proximity Read ↗

Fecal bacteria and short‐chain fatty acids in irritable bowel syndrome: Relations to subtypeSemantic proximity Read ↗

Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors.Semantic proximity Read ↗

Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunctionSemantic proximity Read ↗

Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments.Semantic proximity Read ↗

Post-Infectious Irritable Bowel Syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.